Acadia Healthcare (NASDAQ:ACHC) Director Reeve B. Waud sold 42,302 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 13th. The stock was sold at an average price of $42.02, for a total transaction of $1,777,530.04. Following the completion of the sale, the director now owns 10,088 shares of the company’s stock, valued at $423,897.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Reeve B. Waud also recently made the following trade(s):
- On Friday, December 15th, Reeve B. Waud sold 100,000 shares of Acadia Healthcare stock. The stock was sold at an average price of $31.80, for a total transaction of $3,180,000.00.
NASDAQ:ACHC traded down $1.25 during trading hours on Friday, hitting $39.46. 435,505 shares of the stock traded hands, compared to its average volume of 865,332. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.25 and a quick ratio of 1.25. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $54.34. The company has a market capitalization of $3,593.60, a P/E ratio of 17.16, a P/E/G ratio of 1.33 and a beta of 0.63.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Acadia Healthcare had a net margin of 6.92% and a return on equity of 8.16%. The business had revenue of $724.50 million for the quarter, compared to the consensus estimate of $713.20 million. During the same quarter in the previous year, the firm earned $0.59 earnings per share. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. sell-side analysts anticipate that Acadia Healthcare will post 2.45 earnings per share for the current fiscal year.
A number of large investors have recently modified their holdings of ACHC. Freshford Capital Management LLC purchased a new position in Acadia Healthcare during the fourth quarter valued at approximately $31,835,000. Frontier Capital Management Co. LLC lifted its holdings in Acadia Healthcare by 13.2% during the fourth quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock valued at $94,738,000 after purchasing an additional 337,961 shares in the last quarter. Sapience Investments LLC purchased a new position in Acadia Healthcare during the fourth quarter valued at approximately $10,279,000. Aristotle Capital Management LLC lifted its holdings in Acadia Healthcare by 5.0% during the fourth quarter. Aristotle Capital Management LLC now owns 6,183,866 shares of the company’s stock valued at $201,780,000 after purchasing an additional 297,069 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Acadia Healthcare by 11.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,662,663 shares of the company’s stock valued at $79,408,000 after purchasing an additional 176,020 shares in the last quarter.
A number of brokerages have recently commented on ACHC. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, February 12th. Jefferies Group set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a research note on Tuesday, December 19th. ValuEngine lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday. BMO Capital Markets restated an “outperform” rating and set a $45.00 target price (up from $40.00) on shares of Acadia Healthcare in a research report on Friday, February 23rd. Finally, BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, February 22nd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and an average target price of $44.50.
TRADEMARK VIOLATION NOTICE: “Insider Selling: Acadia Healthcare (ACHC) Director Sells 42,302 Shares of Stock” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/07/reeve-b-waud-sells-42302-shares-of-acadia-healthcare-company-inc-achc-stock.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.